The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
- PMID: 16458258
- DOI: 10.1016/j.bcp.2005.12.033
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Abstract
Cannabis is the most widely used illicit drug in the world. Cannabinoids are used therapeutically by some patients as they have analgesic, anti-emetic and appetite stimulant properties which palliate adverse symptoms. Use of these agents in an oncology setting raises the question of whether they act to modulate the effectiveness of concurrently administered anti-cancer drugs. The transporter, P-glycoprotein (P-gp) confers multiple drug resistance (MDR) by effluxing a diverse array of anti-cancer agents. This study was undertaken to examine the effect of cannabinoids on P-gp. Unlike the known P-gp inhibitor, PSC833, short 1h exposure to three plant-derived cannabinoids, cannabinol (CBN), cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC) and the synthetic cannabinoid receptor agonist, WIN55, 212-2 (WIN) did not inhibit the efflux of the P-gp substrate Rhodamine 123 (Rh123) in either a drug-selected human T lymphoblastoid leukaemia cell line (CEM/VLB(100)) or in a mouse fibroblast MDR1 transfected cell line (77.1). However, in CEM/VLB(100) cells, prolonged 72 h exposure to the cannabinoids, THC and CBD, decreased P-gp expression to a similar extent as the flavonoid, curcumin (turmeric). This correlated with an increase in intracellular accumulation of Rh123 and enhanced sensitivity of the cells to the cytotoxic actions of the P-gp substrate, vinblastine. Taken together, these results provide preliminary evidence that cannabinoids do not exacerbate P-gp mediated MDR. Further, plant-derived cannabinoids are moderately effective in reversing MDR in CEM/VLB(100) cells by decreasing P-gp expression.
Similar articles
-
Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.Cancer Chemother Pharmacol. 2002 May;49(5):391-7. doi: 10.1007/s00280-001-0411-5. Epub 2002 Feb 14. Cancer Chemother Pharmacol. 2002. PMID: 11976833
-
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.J Pharmacol Exp Ther. 2006 May;317(2):850-7. doi: 10.1124/jpet.105.098541. Epub 2006 Jan 26. J Pharmacol Exp Ther. 2006. PMID: 16439618
-
Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.Acta Pharmacol Sin. 2005 Aug;26(8):1009-16. doi: 10.1111/j.1745-7254.2005.00149.x. Acta Pharmacol Sin. 2005. PMID: 16038636
-
Multidrug resistance of acute leukemia and a strategy to overcome it.Int J Hematol. 2000 Dec;72(4):418-24. Int J Hematol. 2000. PMID: 11197207 Review.
-
Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis.Gen Physiol Biophys. 2009;28 Spec No Focus:F89-95. Gen Physiol Biophys. 2009. PMID: 20093732 Review.
Cited by
-
Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.Biomed Res Int. 2020 Aug 13;2020:3902740. doi: 10.1155/2020/3902740. eCollection 2020. Biomed Res Int. 2020. PMID: 32855964 Free PMC article. Review.
-
CB1 and CB2 receptors are novel molecular _targets for Tamoxifen and 4OH-Tamoxifen.Biochem Biophys Res Commun. 2013 Nov 15;441(2):339-43. doi: 10.1016/j.bbrc.2013.10.057. Epub 2013 Oct 19. Biochem Biophys Res Commun. 2013. PMID: 24148245 Free PMC article.
-
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations.Sci Rep. 2021 Jul 22;11(1):14948. doi: 10.1038/s41598-021-94212-6. Sci Rep. 2021. PMID: 34294753 Free PMC article.
-
In Vitro Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function.Cannabis Cannabinoid Res. 2022 Jun;7(3):304-317. doi: 10.1089/can.2020.0053. Epub 2020 Sep 22. Cannabis Cannabinoid Res. 2022. PMID: 33998860 Free PMC article.
-
Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges.Pharmaceuticals (Basel). 2022 Oct 6;15(10):1228. doi: 10.3390/ph15101228. Pharmaceuticals (Basel). 2022. PMID: 36297340 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous